![]() Primacea to Survey Vascular Leaders at VIVA 10iPads to be awarded and survey results to be announced at Conference.
By: Primacea, Inc. The survey addresses current topics including the Zilver PTX and CORAL trial results, endovascular repair of aneurysms of the abdominal and/or thoracic aorta, below the knee procedures, radial access, carotid artery stenting, use of vascular closure devices, renal artery intervention, treatment of superficial venous varicosity disease, hospital input on device selection and off-label use of cardiovascular devices. Each attendee will receive a survey at conference registration; Each physician who completes the survey will be entered into a drawing to win one of three iPads. The first drawing will be held at the Primacea Clinical Leaders Reception on Tuesday, October 19, 2010. Additional drawings will be held Wednesday and Thursday, October 20 and 21, 2010. VIVA, Vascular InterVentional Advances, is the leading professional education conference in the field of vascular medicine and intervention. # # # Primacea, Inc. is the first organization dedicated to serving the best interests of physicians who advance medicine in collaboration with industry. Primacea provides a means for dedicated physicians to have a greater voice in developing strategies that advance patient care. Primacea Data Solutions (http://www.primacea.com/ For more news and information about Primacea, visit http://www.primacea.com. The Primacea name and logo are trademarks of Primacea, Inc. All other companies and products referenced herein are trademarks or registered trademarks of their respective holders. End
|
|